Q&A: Harvard Professor Talks JAMA Study That Looks At 45 Years Of FDA Premarket Data
The study concludes that the regulatory process has become complex and the path to market for some medical devices tricky.
You may also be interested in...
Device makers presented with an affidavit by the US FDA during a facility inspection should walk away as quickly as possible, King & Spalding partner Jessica Ringel advises.
The US agency has announced two additional webinars aimed at labs and manufacturers that are developing – or have developed – diagnostic tests for the coronavirus.
A May recall of 25,000 Super Torque MB Angiographic Catheters with Radiopaque Marker Bands was given the high-risk classification by the US agency on 22 September.